PhRMA CONSIDERING DEFAULT APPROVAL MECHANISM FOR DRUGS ALREADY APPROVED BY EUROPEAN/BRITISH AGENCIES: FDA WOULD HAVE 90-DAY LIMIT TO MAKE DECISION
Executive Summary
PhRMA is considering a default approval mechanism for drugs reviewed and approved by the new European Medicines Evaluation Agency or the U.K.'s Committee on Safety of Medicines as a key part of its legislative proposal for FDA reform.